Press "Enter" to skip to content

Remedisvir not able to reduce corona infection, fails in WHO clinical trial

Washington. So far, 39 million people have been infected with Coronavirus worldwide. Out of this, 11 lakh 2 thousand people have lost their lives. At the same time, 2 crore 93 lakh patients have been cured. American pharmaceutical company Gilead’s first drug to treat corona Ramdesvir (Remdesivir) was considered to be effective to some extent, but now the World Health Organization (WHO) has declared this drug to be a failure in preventing deaths from corona. The World Health Organization gave the information after the results of a clinical trial. Recently, when American President Donald Trump Corona became infected, he was also injected with Remedisvir.

In May this year, when it was announced that Kovid-19 patients were Remadecivir antiviral medication If it is proved to be effective, then a lot of expectations were created about it. Initial investigations revealed that this drug could cure patients infected with the corona virus quickly. This had happened in some cases, but now this statement of the World Health Organization has caused a big shock to the patients who are being treated for corona from Remedesvir.

Eli Lilly prohibits monoclone antibody treatment at last stage, says safety is most important

This drug has also been used earlier for Ebola virus. Apart from this, Remdesivir is also effective on Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). MERS and SARS are also diseases caused by corona virus like Kovid-19.

The World Health Organization conducted a clinical trial of Remedisvir on 11,266 adult patients from 30 countries. It included four possible drug regimens including Remedesivir as well as these patients including hydroxychloroquine, anti-HIV drug combination lopinavir / ritonavir and interferon. Whose effects were evaluated.

The WHO study on Thursday found that it did not affect 28-day mortality or recovery of hospitalized patients with Kovid-19. The details of the clinical trial are yet to be reviewed in detail. This primary study has been uploaded to the preprint server medRxiv.

WHO Chief Scientist Soumya Swaminathan said on Wednesday that during the study, hydroxychloroquine and lopinavir / risinavir were stopped in June after proving to be ineffective, but related trials are underway in more than 500 hospitals and 30 countries. Swaminathan said, “We are monitoring monoclonal anti-bodies. In a few days the results will be understood.”

World Hand Wash Day: not only corona virus can be eliminated by washing hands

According to Soumya Swaminathan, by the end of the year or by the beginning of next year, the corona vaccine will come. Swaminathan said on Monday, ‘Currently 40 companies are developing vaccines under the banner of WHO. Trial of 10 of them is in the third phase. We will have the vaccine by the end of 2020 or by early 2021.


Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *